118 related articles for article (PubMed ID: 4905918)
21. Field evaluation of live virus mumps vaccine.
Sugg WC; Finger JA; Levine RH; Pagano JS
J Pediatr; 1968 Apr; 72(4):461-6. PubMed ID: 4869563
[No Abstract] [Full Text] [Related]
22. The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren.
Christenson B; Heller L; Böttiger M
J Biol Stand; 1983 Oct; 11(4):323-31. PubMed ID: 6643511
[TBL] [Abstract][Full Text] [Related]
23. Jeryl Lynn strain live attenuated mumps virus vaccine. Durability of immunity following administration.
Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
JAMA; 1968 Jan; 203(1):14-8. PubMed ID: 5694077
[No Abstract] [Full Text] [Related]
24. In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.
Connaughton SM; Wheeler JX; Vitková E; Minor P; Schepelmann S
Vaccine; 2015 Aug; 33(36):4586-93. PubMed ID: 26187256
[TBL] [Abstract][Full Text] [Related]
25. Use of attenuated live mumps virus vaccine during a "virgin soil" epidemic of mumps on St. Paul Island, Alaska.
Maynard JE; Shramek G; Noble GR; Deinhardt F; Clark P
Am J Epidemiol; 1970 Nov; 92(5):301-6. PubMed ID: 5473777
[No Abstract] [Full Text] [Related]
26. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.
Wellington K; Goa KL
Drugs; 2003; 63(19):2107-26. PubMed ID: 12962524
[TBL] [Abstract][Full Text] [Related]
27. Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.
Stokes J; Weibel RE; Villarejos VM; Arguedas JA; Buynak EB; Hilleman MR
JAMA; 1971 Oct; 218(1):57-61. PubMed ID: 4937795
[No Abstract] [Full Text] [Related]
28. [Anti-mumps vaccination with a live attenuated vaccine in a children's collective].
Drouhet V; Celers J; Minvielle A
Bull Acad Natl Med; 1970 Jun; 154(23):570-6. PubMed ID: 4922864
[No Abstract] [Full Text] [Related]
29. Vaccination of school children with live mumps virus vaccine.
Furesz J; Nagler FP
Can Med Assoc J; 1970 May; 102(11):1153-5. PubMed ID: 5420994
[TBL] [Abstract][Full Text] [Related]
30. Combined live measles, mumps, and rubella virus vaccines.
Buynak EB; Weibel RE; Whitman JE; Stokes J; Hilleman MR
JAMA; 1969 Mar; 207(12):2259-62. PubMed ID: 5818433
[No Abstract] [Full Text] [Related]
31. [Adverse effects following vaccinations and effectiveness of different live vaccines against mumps].
Magdzik W; Zieliński A
Przegl Epidemiol; 2002; 56(3):377-89. PubMed ID: 12608087
[TBL] [Abstract][Full Text] [Related]
32. A field trial with live attenuated mumps virus vaccine: a serological study.
Rossier E; Meunier J; Baker F; Marchessault V
Can J Microbiol; 1971 Jul; 17(7):929-34. PubMed ID: 5094603
[No Abstract] [Full Text] [Related]
33. [Certain problems with limits of immunity against measles, mumps and rubella].
Magdzik W
Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
[TBL] [Abstract][Full Text] [Related]
34. Studies on live attenuated mumps vaccine. II. Follow-up study on the efficacy of Biken Vaccine.
Isomura S; Ozaki T; Morishima T; Nagayoshi S; An S
Biken J; 1976 Sep; 19(3):115-8. PubMed ID: 1016214
[TBL] [Abstract][Full Text] [Related]
35. Development and biological properties of a new live attenuated mumps vaccine.
Saika S; Kidokoro M; Kubonoya H; Ito K; Ohkawa T; Aoki A; Nagata N; Suzuki K
Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):89-99. PubMed ID: 16647119
[TBL] [Abstract][Full Text] [Related]
36. Mumps and varicella vaccines.
Dudgeon JA
Arch Dis Child; 1980 Jan; 55(1):3-6. PubMed ID: 6990874
[No Abstract] [Full Text] [Related]
37. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells.
Glück R; Hoskins JM; Wegmann A; Just M; Germanier R
Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774
[TBL] [Abstract][Full Text] [Related]
38. Matched case-control study of effectiveness of live, attenuated S79 mumps virus vaccine against clinical mumps.
Fu C; Liang J; Wang M
Clin Vaccine Immunol; 2008 Sep; 15(9):1425-8. PubMed ID: 18667635
[TBL] [Abstract][Full Text] [Related]
39. [Specific prophylaxis of epidemic parotitis with live vaccine (Sofia-6 strain). VI. The epidemiological effectiveness of vaccination].
Demirov GP; Odiseev KH
Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):81-5. PubMed ID: 4450862
[No Abstract] [Full Text] [Related]
40. Effectiveness of Jeryl Lynn-containing vaccine in Spanish children.
Castilla J; García Cenoz M; Arriazu M; Fernández-Alonso M; Martínez-Artola V; Etxeberria J; Irisarri F; Barricarte A
Vaccine; 2009 Mar; 27(15):2089-93. PubMed ID: 19356610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
